SPOTLIGHT -
BREAKING NEWS: FDA approves Novaliq’s cyclosporine ophthalmic solution for treatment of dry eye disease
Podcast: Wet AMD and the treatment burden on patients
OKYO Pharma announces dosing of first patient in randomized portion of phase 2 trial of OK-101
Podcast: AI/MR in ophthalmology: The future is now
Joey Gase named ambassador by National Keratoconus Foundation
Vyluma announces FDA acceptance of NDA for NVK002 for treatment of pediatric myopia